Intrasense and Guerbet have secured PMDA certification in Japan for DUOnco™ Pancreas, an AI-powered software designed to support pancreatic CT scan analysis.
ByNN Desk
NervNow spoke with Anubhav Mehtrotra, VP, CX, Tata 1mg, about how AI should behave in that context, what genuine digital empathy actually looks like in practice, and why the hardest part of the work has very little to do with the technology itself.
Announced deployments and verified patient outcomes in AI radiology and screening outside metro India tell very different stories. Understanding that gap matters for every health system decision-maker evaluating these tools.
Gabify funding highlights growing use of AI in early diagnosis of speech and neurodevelopmental disorders, where access and screening delays remain major challenges.
ByNN Desk
In an interview with NervNow, Surjeet Thakur, CEO & Founder of TrioTree Technologies, speaks on AI in clinical decision-making, the reality of managing 10 million+ patient records, and what healthcare leaders must invest in today to stay competitive by 2030
